Pulmonx CORP Form 4 insider transactions

Director Thomas William Burns was granted 40,000 restricted stock units in Pulmonx Corporation.

Director Richard Ferrari was granted 40,000 restricted stock units in Pulmonx Corporation.

Director Daniel P. Florin was granted 40,000 restricted stock units in Pulmonx Corporation.

Director Georgia Melenikiotou was granted 40,000 restricted stock units in Pulmonx Corporation.

Director Tiffany Sullivan was granted 40,000 restricted stock units in Pulmonx Corporation.

Pulmonx Corporation director Dana G. Mead Jr. was granted 40,000 restricted stock units as part of an equity compensation award.

Pulmonx Corp. reports that Chief Science & Technology Officer Radhakrishnan Srikanth sold shares to cover tax obligations related to vested Restricted Stock Units.

Pulmonx Corp's General Counsel, David Aaron Lehman, sold company shares to cover tax obligations related to vesting Restricted Stock Units.

Pulmonx Corp reports a Form 4 filing detailing the sale of common stock by Chief Commercial Officer Geoffrey Beran to cover tax withholding obligations.

Pulmonx's Chief Science & Technology Officer, Srikanth Radhakrishnan, sold 10,483 shares to cover tax obligations from RSU vesting and was granted 175,000 new Restricted Stock Units.

Pulmonx Corp's President and CEO, Glendon E. French III, sold shares to cover tax withholding obligations related to vested Restricted Stock Units.

Pulmonx's Chief Commercial Officer, Geoffrey Beran Rose, sold shares to cover tax obligations related to RSU vesting and received a new grant of 100,000 Restricted Stock Units.

Pulmonx General Counsel David Aaron Lehman reported the grant of 150,000 Restricted Stock Units and the sale of 12,237 shares to cover tax obligations related to prior RSU vestings.

Pulmonx Director Daniel P. Florin sold 23,321 shares of common stock for a weighted average price of $1.99 per share, pursuant to a Rule 10b5-1 trading plan.

Pulmonx Corp's President and CEO, Glendon E. French III, increased his beneficial ownership through a significant RSU and PSU grant while also selling shares to cover tax obligations.

Pulmonx Chief Commercial Officer Geoffrey Beran Rose sold 6,322 shares of common stock on December 1, 2025, to cover tax withholding obligations related to RSU vesting.

Pulmonx Corp's Chief Operating Officer and Chief Financial Officer, Derrick Sung, was granted 1.2 million Restricted Stock Units and 400,000 Performance Stock Units, effective December 1, 2025.

Pulmonx Corp's General Counsel, David Aaron Lehman, sold 10,278 shares of common stock to cover tax withholding obligations related to RSU vesting.

Pulmonx Corporation's President and CEO, Steven S. Williamson, sold common stock to cover tax withholding obligations related to RSU vesting.

Pulmonx Corporation's Chief Financial Officer, Mehul Joshi, sold 7,936 shares of common stock to cover tax withholding obligations related to RSU vesting.

Pulmonx Chief Commercial Officer Geoffrey Beran Rose sold shares to cover tax withholding obligations related to RSU vesting.

Pulmonx General Counsel David Aaron Lehman sold 9,769 shares of common stock to cover tax withholding obligations related to RSU vesting.

Richard Ferrari, a Director at Pulmonx Corp, reported the sale of 8,000 shares of the company's common stock on June 12, 2025, reducing his beneficial ownership to 87,024 shares.

Pulmonx Corporation's Director, Daniel P. Florin, has acquired 23,321 shares of common stock, increasing his beneficial ownership to 117,231 shares.

Pulmonx Corporation Director Tiffany Sullivan was granted 37,153 shares of common stock in the form of Restricted Stock Units, increasing her direct beneficial ownership to 75,199 shares.

Pulmonx Corporation's Director, Thomas William Burns, was granted 37,153 Restricted Stock Units, increasing his direct beneficial ownership to 73,399 shares.

Pulmonx Corporation's President and CEO, Steven S. Williamson, sold 9,923 shares of common stock for $3.13 per share to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Pulmonx Corporation's Director, Richard Ferrari, was granted 37,153 Restricted Stock Units, increasing his beneficial ownership to 95,024 shares.

Pulmonx Corporation's Chief Financial Officer, Mehul Joshi, sold 8,061 shares of common stock for approximately $25,229.53 to satisfy tax withholding obligations related to the vesting of Restricted Stock Units.

Pulmonx Corporation's Director, Glendon E. French III, was granted 37,153 Restricted Stock Units, increasing his beneficial ownership to over 1 million shares.